BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 38637820)

  • 1. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases.
    Downs-Canner S; Shuai Y; Ramalingam L; Pingpank JF; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA
    J Surg Res; 2017 Nov; 219():194-201. PubMed ID: 29078882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Risk Peritoneal Mesothelioma: Does Metronomic Chemotherapy Have a Role?
    Kammar P; Garach N; Bhatt A; Anam J; Maniar V; Gore A; Mehta S
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):181-188. PubMed ID: 37359939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Descriptive Analysis of Patients Undergoing Cytoreductive Surgery for the First Peritoneal Recurrence from Adult Granulosa Cell Tumours: Focus on Disease Distribution, Morphology of Peritoneal Disease and the Role of HIPEC - a Retrospective Study by INDEPSO.
    Sinukumar S; Ray M; Damodaran D; Katdare N; Vikram S; Shaikh S; Patel A; Bhatt A
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):82-91. PubMed ID: 37359921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive Surgery with HIPEC as Primary Treatment for Advanced Epithelial Ovarian Carcinoma: Upfront or Interval-ISPSM Collaborative Study.
    Somashekhar SP; Ramya Y; Ashwin KR; Fernandes AM; Ahuja V; Namachivayam AK; Kumar CR
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):226-232. PubMed ID: 37359935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases.
    Chatterjee A; Kazi M; Ostwal V; Ramaswamy A; Desouza A; Saklani A
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):192-197. PubMed ID: 37359918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection Factors for Treatment and Stratification of Rare Abdominal or Pelvic Tumors with Peritoneal Metastases.
    Sugarbaker PH
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):7-14. PubMed ID: 37359915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
    Narasimhan V; Tan S; Kong J; Pham T; Michael M; Ramsay R; Warrier S; Heriot A
    Colorectal Dis; 2020 Nov; 22(11):1482-1495. PubMed ID: 32027455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery.
    Sarofim M; Wijayawardana R; Ahmadi N; Barat S; Liauw W; Morris DL
    World J Surg Oncol; 2024 Apr; 22(1):103. PubMed ID: 38637820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
    Zhou S; Jiang Y; Liang J; Pei W; Zhou Z
    World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Wach MM; Nunns G; Hamed A; Derby J; Jelinek M; Tatsuoka C; Holtzman MP; Zureikat AH; Bartlett DL; Ahrendt SA; Pingpank JF; Choudry MHA; Ongchin M
    Ann Surg Oncol; 2024 Apr; 31(4):2391-2400. PubMed ID: 38270826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of Stable Lung Colorectal Metastases on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Pantelis A; Ben-Yaacov A; Adileh M; Schtrechman G; Shacham-Shmueli E; Boursi B; Margalit O; Halpern N; Mor E; Assaf D; Maximiliano K; Nissan A; Laks S
    J Gastrointest Surg; 2022 Aug; 26(8):1724-1731. PubMed ID: 35768716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry.
    Kelly ME; O'Sullivan NJ; Bolger JC; Polignano F; Youssef H; Renehan A; Malcomson L; Alves S; Cecil T; Mulsow J; Moran B; Mohamed F;
    Br J Cancer; 2023 Jan; 128(1):42-47. PubMed ID: 36347966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited commentary: Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
    Pocard M
    World J Surg; 2024 Apr; 48(4):879-880. PubMed ID: 38447984
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.